Molecular cancer therapy: Resistin, a pro-inflammatory cytokine, inhibits cancer development by suppressing the expression of nucleotide sanitizing enzyme MTH1/NUDT1, 18/April/2014, 4.46 am

Therapeutic insights into the treatment of triple-negative mammary cancer: Metformin, the widely used drug for TIIDM, suppresses the expression of X‑linked inhibitor of apoptosis via up regulation of its target gene, 18/April/2014, 4.37 am
May 17, 2014
An insight into activating tumor suppressor network in human cancer cells: Tumor suppressor miRNA-99 promotes widespread miRNA biogenesis via down regulation of its target gene, 18/May/2014, 5.03 am
May 17, 2014
Show all

A study from Karolinska Institutet, Stockholm, Sweden shows that MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. 

This study was published in the April 10, 2014 Nature by Prof. Dr Thomas H, Dr Gad H and others from Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMDreports here that: Molecular cancer therapy: Resistin, a pro-inflammatory cytokine, inhibits cancer development by suppressing the expression of nucleotide sanitizing enzyme MTH1/NUDT1

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular cancer therapy: Resistin, a pro-inflammatory cytokine, inhibits cancer development by suppressing the expression of nucleotide sanitizing enzyme MTH1/NUDT1, 18/April/2014, 4.46 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.